Anticoagulants may prolong lives of prostate cancer patients

02/22/2013 | HealthDay News

Researchers tracked nearly 250 patients with advanced or spreading prostate cancer and found a 39% increase in survival among those treated with anticoagulants. Because of bleeding risks, the drugs should be used carefully, experts cautioned. The study examined patients being treated with chemotherapy and was reported at a meeting of the American Society of Clinical Oncology.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID